Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News ESC 2025

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

Michael O'Riordan

September 01, 2025

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

News Daily News

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

L.A. McKeown

November 25, 2024

News Daily News

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Yael L. Maxwell

August 01, 2024

News Daily News

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

L.A. McKeown

December 08, 2023

News Daily News

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

L.A. McKeown

September 14, 2023

News Daily News

ECG Images, Thanks to AI, Can Be Used to Detect Low LVEF

Caitlin E. Cox

August 02, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

News Features

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Shelley Wood

December 13, 2021

News Daily News

As Amyloidosis Field Explodes, Physicians Need to Spot and Treat

Todd Neale

October 20, 2021

News Conference News ACC 2021

RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients

Todd Neale

May 17, 2021

News Daily News

Renal Denervation for Chagas Disease-Related HF Proves Safe in Pilot Study

Todd Neale

August 01, 2019

News Conference News ESC Heart Failure 2019

Weaning Off Diuretics in Stable Heart Failure? ReBIC-1 Hints at Possibilities

Shelley Wood

May 28, 2019

News Conference News ACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Shelley Wood

March 26, 2019

News Daily News

AHA Scientific Statement Aims to Raise Awareness of Chagas Disease and Risk for Cardiomyopathy

Lucy Hicks

August 24, 2018

Advertisement

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

August 2025 Dispatch for the CV Team

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

ECG Images, Thanks to AI, Can Be Used to Detect Low LVEF

February 2023 News Roundup

June 2022 News Roundup

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

As Amyloidosis Field Explodes, Physicians Need to Spot and Treat

RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients

Renal Denervation for Chagas Disease-Related HF Proves Safe in Pilot Study

Weaning Off Diuretics in Stable Heart Failure? ReBIC-1 Hints at Possibilities

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

AHA Scientific Statement Aims to Raise Awareness of Chagas Disease and Risk for Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content